Rho-kinase contributes to hypoxia/reoxygenation-induced cerebral endothelial dysfunction

Area of Science:

• Neuroscience
• Vascular Biology
• Cellular Physiology

Background:

• Hypoxia/reoxygenation (H/R) induces cerebral endothelial dysfunction, but intracellular mechanisms are not fully understood.
• Superoxide production is implicated, yet specific pathways require elucidation.

Purpose of the Study:

• To investigate the role of Rho-kinase and its interplay with nitric oxide (NO) in H/R-induced cerebral endothelial dysfunction.
• To identify potential therapeutic interventions for H/R-mediated vascular impairment.

Main Methods:

• In vitro assessment of rat posterior cerebral arteries, measuring arterial diameter and intraluminal pressure.
• Quantification of vascular NO metabolites (nitrate/nitrite).
• Pharmacological inhibition of Rho-kinase (Y27632), protein kinase C (chelerythrine), and NO synthase (L-NAME); administration of L-arginine and an NO donor (diethylenetetraamine-NONOate).

Main Results:

• H/R selectively impaired endothelium-dependent vasodilation to acetylcholine (ACh) and reduced NO production.
• Rho-kinase inhibition (Y27632) reversed H/R-induced vasodilation impairment, while protein kinase C inhibition did not.
• NO deficiency was confirmed, as L-NAME did not prevent H/R-induced dysfunction, but an NO donor normalized vasodilation.

Conclusions:

• H/R-induced cerebral endothelial dysfunction involves Rho-kinase activation and associated NO deficiency.
• Targeting the Rho-kinase pathway or augmenting NO levels may offer protective strategies against H/R-mediated endothelial damage.